Position in INSM
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,867,022
-$1,142,400 QoQ
Shares Held
17,511
-4.9% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#290
of 663 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Wealthfront Advisers LLC holds $35,327,037 across 19 Biotechnology names. INSM ranks #4 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
41,608 | $20,667,941 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,006 | $4,368,521 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,554 | $2,876,040 | |
| 4 | INSM |
INSMED Inc
This page
|
17,511 | $1,867,022 | |
| 5 | INCY |
Incyte Corp
|
9,753 | $1,105,600 | |
| 6 | MRNA |
Moderna, Inc.
|
15,621 | $1,093,938 | |
| 7 | SLS |
SELLAS Life Sciences Group, Inc.
|
39,822 | $587,772 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
8,602 | $469,153 |
All Filings in INSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,867,022 | 17,511 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,009,422 | 18,404 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,738,833 | 9,991 | Shares | Sole | 2026-01-30 | |
| No filing history on record for this holder in this stock. | ||||||